← Back to patent-cliff list
CAS 1210039-33-0
(4aS,4bR,7aS,8aR)-2-(4-methoxyphenyl)hexahydrofuro[3',2':3,4]cyclopenta[1,2-d][1,3]dioxin-6(4H)-one
Codes：LUBI-051
Application context (from source-drug indications)
便秘芦比前列酮阿片类药物引起的便秘芦比前列酮慢性特发性便秘芦比前列酮药物相关的副作用和不良反应芦比前列酮非酒精性脂肪性肝炎芦比前列酮腹膜癌芦比前列酮
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 芦比前列酮Lubiprostone | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
dimethyl (3,3-difluoro-2-oxoheptyl)phosphonate→(5-carboxypentyl)triphenylphosphonium bromide→(3aR,4S,5R,6aS)-5-hydroxy-4-(hydroxymethyl)hexahydro-2H-cyclopenta[b]furan-2-one→benzyl (Z)-7-((1R,2S,3R,5S)-5-hydroxy-2-(hydroxymethyl)-3-((4-methoxybenzyl)oxy)cyclopentyl)hept-5-enoate→benzyl (Z)-7-((1R,2R,3R)-2-((E)-4,4-difluoro-3-oxooct-1-en-1-yl)-3-((4-methoxybenzyl)oxy)-5-oxocyclopentyl)hept-5-enoate→(3aR,4S,5R,6aS)-4-(hydroxymethyl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate→1-(dimethoxymethyl)-4-methoxybenzene→(4aS,4bR,7aS,8aR)-2-(4-methoxyphenyl)hexahydrofuro[3',2':3,4]cyclopenta[1,2-d][1,3]dioxin-6(4H)-one→(3aR,4S,5R,6aS)-4-(hydroxymethyl)-5-((4-methoxybenzyl)oxy)hexahydro-2H-cyclopenta[b]furan-2-ol→(Z)-7-((1R,2S,3R,5S)-5-hydroxy-2-(hydroxymethyl)-3-((4-methoxybenzyl)oxy)cyclopentyl)hept-5-enoic acid→benzyl (Z)-7-((1R,2R,3R)-2-formyl-3-((4-methoxybenzyl)oxy)-5-oxocyclopentyl)hept-5-enoate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.